{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "15095149", "DateCompleted": {"Year": "2004", "Month": "06", "Day": "30"}, "DateRevised": {"Year": "2015", "Month": "11", "Day": "19"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0032-0943", "JournalIssue": {"Volume": "70", "Issue": "4", "PubDate": {"Year": "2004", "Month": "Apr"}}, "Title": "Planta medica", "ISOAbbreviation": "Planta Med"}, "ArticleTitle": "Effects of quercetin treatment on vascular function in deoxycorticosterone acetate-salt hypertensive rats. Comparative study with verapamil.", "Pagination": {"StartPage": "334", "EndPage": "341", "MedlinePgn": "334-41"}, "Abstract": {"AbstractText": ["This study analysed and compared the effects of chronic oral treatment with quercetin or verapamil on systolic blood pressure and vascular function in deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Quercetin and verapamil inhibited the development of DOCA-salt-induced hypertension in a similar manner. DOCA-salt-hypertensive rats showed potassium depletion and oxidative stress, prevented only by concomitant quercetin administration. Quercetin and verapamil treatments reduced the endothelium-independent hyper-reactivity to KCl observed in the aorta of DOCA-salt-hypertensive rats, but only quercetin increased the contractile responses to angiotensin II, improved endothelial dysfunction and restored basal aortic Cu/Zn SOD expression, altered in DOCA-salt-treated rats. In conclusion, quercetin and verapamil show similar antihypertensive effects in mineralocorticoid hypertension, but quercetin was superior to verapamil in improving endothelial-dependent aortic dilatation, suggesting a better vascular protection in this volume expansion hypertension model."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, School of Pharmacy, University of Granada, Granada, Spain."}], "Identifier": [], "LastName": "Galisteo", "ForeName": "Milagros", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Garc\u00eda-Saura", "ForeName": "Mar\u00eda Francisca", "Initials": "MF"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jim\u00e9nez", "ForeName": "Rosario", "Initials": "R"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Villar", "ForeName": "Inmaculada Concepci\u00f3n", "Initials": "IC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wangensteen", "ForeName": "Rosemary", "Initials": "R"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zarzuelo", "ForeName": "Antonio", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Vargas", "ForeName": "F\u00e9lix", "Initials": "F"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Duarte", "ForeName": "Juan", "Initials": "J"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Planta Med", "NlmUniqueID": "0066751", "ISSNLinking": "0032-0943"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antihypertensive Agents"}, {"RegistryNumber": "40GP35YQ49", "NameOfSubstance": "Desoxycorticosterone"}, {"RegistryNumber": "451W47IQ8X", "NameOfSubstance": "Sodium Chloride"}, {"RegistryNumber": "660YQ98I10", "NameOfSubstance": "Potassium Chloride"}, {"RegistryNumber": "9IKM0I5T1E", "NameOfSubstance": "Quercetin"}, {"RegistryNumber": "CJ0O37KU29", "NameOfSubstance": "Verapamil"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["administration & dosage", "pharmacology", "therapeutic use"], "DescriptorName": "Antihypertensive Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Aorta"}, {"QualifierName": ["drug effects"], "DescriptorName": "Blood Pressure"}, {"QualifierName": [], "DescriptorName": "Desoxycorticosterone"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": ["chemically induced", "prevention & control"], "DescriptorName": "Hypertension"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug effects"], "DescriptorName": "Muscle Contraction"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Potassium Chloride"}, {"QualifierName": ["administration & dosage", "pharmacology", "therapeutic use"], "DescriptorName": "Quercetin"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": [], "DescriptorName": "Sodium Chloride"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Verapamil"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2004", "Month": "4", "Day": "20", "Hour": "5", "Minute": "0"}, {"Year": "2004", "Month": "7", "Day": "1", "Hour": "5", "Minute": "0"}, {"Year": "2004", "Month": "4", "Day": "20", "Hour": "5", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["15095149", "10.1055/s-2004-818945"]}}], "PubmedBookArticle": []}